A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Carcinogenesis, 30, 1, S. 59-64
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg, Oxford University Press (OUP)
- (wann)
-
2008
- Urheber
-
Tchatchou, Sandrine
Jung, Anke
Hemminki, Kari
Sutter, Christian
Wappenschmidt, Barbara
Bugert, Peter
Weber, Bernhard H.F.
Niederacher, Dieter
Arnold, Norbert
Varon-Mateeva, Raymonda
Ditsch, Nina
Meindl, Alfons
Schmutzler, Rita K.
Bartram, Claus R.
Burwinkel, Barbara
- DOI
-
10.1093/carcin/bgn253
- URN
-
urn:nbn:de:bvb:384-opus4-845148
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tchatchou, Sandrine
- Jung, Anke
- Hemminki, Kari
- Sutter, Christian
- Wappenschmidt, Barbara
- Bugert, Peter
- Weber, Bernhard H.F.
- Niederacher, Dieter
- Arnold, Norbert
- Varon-Mateeva, Raymonda
- Ditsch, Nina
- Meindl, Alfons
- Schmutzler, Rita K.
- Bartram, Claus R.
- Burwinkel, Barbara
- Universität Augsburg, Oxford University Press (OUP)
Entstanden
- 2008
Ähnliche Objekte (12)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Immunotherapy: new options in breast cancer treatment
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Immunotherapy: new options in breast cancer treatment
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Immunotherapy: new options in breast cancer treatment
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers